Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples